Publications by authors named "Tamas Acs"

Claim this Profile
A
A phase III, multicentre, randomised, investigator-masked, cross-over, comparative, non-inferiority trial evaluating the efficacy and tolerability of generic preservative-free Latanoprost (Polpharma S.A.) compared to Xalatan (Pfizer) in patients with ocular hypertension or primary open-angle glaucoma.
Norbert Czumbel, Tamas Acs, Gyorgy Bator, Agnes Halmosi, Evgeniy A Egorov

BMC Ophthalmolยท July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis